F. Doyle

Molecular Biology · Diabetes Care · 2000–2019

A researcher in the Science corpus: 6 papers; trusts 5 researchers and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

Whom F. Doyle trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Bernhard O. Palsson
  2. Jeremy S. Edwards
  3. C. Schilling
  4. Rafael U. Ibarra
  5. David Letscher

Who trusts F. Doyle overall

  1. Daniel Machado
  2. Ali R. Zomorrodi
  3. Nathan D. Price

Papers from F. Doyle's perspective

Ordered by how strongly the researchers F. Doyle trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Theory for the systemic definition of metabolic pathways and their use in interpreting metabolic function from a pathway-oriented perspective. (Journal of Theoretical Biology)
  2. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. (Science)
  3. In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data (Nature Biotechnology)
  4. A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression (Nature Genetics)
  5. Coordination of circadian timing in mammals (Nature)
  6. Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. (Neuron)
  7. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial (Journal of the American Medical Association (JAMA))
  8. Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials (Diabetes Care)
  9. Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities (Diabetes Technology & Therapeutics)
  10. Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. (Cell)

Their papers